Evidence map›Paper›PMID 42116278›Full record

ArticleMedicine2026

Causal effects of endometriosis on serum 25-hydroxyvitamin D: Evidence from Mendelian randomization study.

Hongkun Jiang, Yinghua Tang, Ximei Huang, Zila Wang, Faquan Lin

Abstract read
In one paragraph

Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hongkun JiangDepartment of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Nanning, Guangxi, China.
Yinghua TangDepartment of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Nanning, Guangxi, China.
Ximei HuangDepartment of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Nanning, Guangxi, China.
Zila WangDepartment of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Nanning, Guangxi, China.
Faquan LinDepartment of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Nanning, Guangxi, China.ORCID 0000-0002-8631-4339

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The potential bidirectional causal relationship between endometriosis and serum 25-hydroxyvitamin D has been previously investigated. Nevertheless, the results could be impacted by confounding factors and reverse causality because of the nature of observational research. Mendelian randomization (MR) circumvents the drawbacks of observational studies by providing estimates of unconfounded causal effects. We used bi-directional MR analysis to determine whether serum 25-hydroxyvitamin D had a causal influence on endometriosis and vice versa. Additionally, using heterogeneity and sensitivity analyses, we explored the heterogeneity and pleiotropy of effect estimates. Similarly, we investigated the causal correlation between endometriosis and 25-hydroxyvitamin D through reverse-direction MR. In forward-direction MR, we selected 95 single-nucleotide polymorphisms (SNPs) as instrumental variants (IVs) to examine the potential causal influence between 25-hydroxyvitamin D and endometriosis. And we selected 9 SNPs as IVs for reverse-direction MR analyses to examine whether endometriosis has a causal influence on serum 25-hydroxyvitamin D. We found suggestive evidence that endometriosis contributes to higher serum 25-hydroxyvitamin D (β: 0.010, 95% CI: 0.002-0.02, P = .016). Our data suggest that serum 25-hydroxyvitamin D levels may be a consequence of endometriosis rather than a causal risk factor, and its potential role in the disease process warrants further investigation.

Indexed as

EndometriosisMendelian Randomization AnalysisVitamin DFemaleGenetic Predisposition to DiseaseHumansPolymorphism, Single Nucleotide25-hydroxyvitamin DVitamin Dendometriosisinstrumental variantMendelian randomizationserum 25-hydroxyvitamin Dsingle-nucleotide polymorphism

Identifiers

PMID42116278
PMCPMC13166774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.